CoChat

Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)

Open access
on behalf of the European Conference on Infections in Leukemia (ECIL), Maschmeyer, Georg, De Greef, Julien, Mellinghoff, Sibylle C., Nosari, Annamaria, Thiebaut-Bertrand, Anne, Bergeron, Anne, Franquet, Tomas, Blijlevens, Nicole M. A., Maertens, Johan A. · 2019 · Leukemia
Cited by 186

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

A multitude of new agents for the treatment of hematologic malignancies has been introduced over the past decade. Hematologists, infectious disease specialists, stem cell transplant experts, pulmonologists and radiologists have met within the framework of the European Conference on Infections in Leukemia (ECIL) to provide a critical state-of-the-art on infectious complications associated with immunotherapeutic and molecular targeted agents used in clinical routine. For brentuximab vedotin, blinatumomab, CTLA4- and PD-1/PD-L1-inhibitors as well as for ibrutinib, idelalisib, HDAC inhibitors, mTOR inhibitors, ruxolitinib, and venetoclax, a detailed review of data available until August 2018 has been conducted, and specific recommendations for prophylaxis, diagnostic and differential diagnostic procedures as well as for clinical management have been developed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41375-019-0388-x

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 186

Metadata

Authors
(ECIL), O. B. O. T. E. C. O. I. I. L., Maschmeyer, G., De Greef, J., Mellinghoff, S. C., Nosari, A., Thiebaut-Bertrand, A., Bergeron, A., Franquet, T., Blijlevens, N. M. A., & Maertens, J. A.
Venue
Leukemia
Published
2019-01-30
Volume
33
Issue
4
Pages
844-862
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2913989733
Cited by
186
References
27
FWCI
10.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). https://app.cochat.ai/papers/10.1038/s41375-019-0388-x
The paper
(ECIL), O. B. O. T. E. C. O. I. I. L., Maschmeyer, G., De Greef, J., Mellinghoff, S. C., Nosari, A., Thiebaut-Bertrand, A., Bergeron, A., Franquet, T., Blijlevens, N. M. A., & Maertens, J. A. (2019). Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia. https://doi.org/10.1038/s41375-019-0388-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.